Think You Know the Latest in AAN MS Research?
Do you remember the MS research presented at AAN? Test your knowledge now and see how you rank!
Read More
Ad Code: Sanofi - Display Banners Conference - Dec - 85690
Shared Decision-Making Tool May Improve Treatment Adherence for Patients With MS
Decision support tools help patients with MS more effectively engage with their providers and adhere to their treatment.
Read More
PIRA Represents Most Common Form of Disability Accrual in Relapsing-Remitting MS
Key risk factors for progression independent of relapse activity in relapsing-remitting MS include age and longer disease duration.
Read More
Q&A: Examining Emerging Therapies to Restore Function in CNS Diseases in MS
More targeted, higher efficacious medications can drastically reduce the risk for accruing disability in newly diagnosed patients with MS.
Read More
In Primary Progressive MS, Age & Follow-Up Duration Predict Disease Activity
For patients with primary progressive MS, age is a particularly important factor that predicts disease activity.
Read More
Q&A: Sharing Knowledge Fosters a Better Understanding of MS
Progression independent of relapse activity explains why certain patients with MS continue to worsen clinically without MRI evidence of new lesions.
Read More
Key Presentations Focused on MS
Check out the key presentations from AAN Fall Clinical on MS. And follow along for more from AAN.
Read More
What Do You Remember From AAN?
What do you remember from AAN? Test your knowledge now!
Read More
Agenda at a Glance, AAN
Take a look at the schedule for AAN Fall Conference. And follow along at PW for conference coverage.
Read More
Fun Facts & FAQs
Take a look at some of the fun facts about AAN Fall Conference. And follow PW for conference coverage.
Read More